Relative Bioavailability of Meloxicam 2 x 7.5 mg Tablets Compared to 15 mg Tablet and Dose Proportionality Over a Dose Range of 7.5 mg and 15 mg in Healthy Volunteers
Clinical trial NCT02276352 · COMPLETED
Trial details
- NCT number
- NCT02276352
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1999-06-01
- Primary completion
- 1999-08-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.